Packaging & Paper Global On demand · 24-48h

Global Automatic Medicine Blister Packaging Machine Market Strategic Research Report

Global Automatic Medicine Blister Packaging Machine Market S…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Automatic Medicine Blister Packaging Machine Market
$5572025
5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Roller Automatic Medicine Blister Packaging Machine, Tablet Automatic Medicine Blister Packaging Machine

By Application: Tablets, Capsules, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Uhlmann, IMA Group, Marchesini, Romaco, Körber Pharma, Pharmaworks, Hoong-A, CAM, Mutual Corporation, ACG Pam Pac, Algus Packaging, Hualian Pharmaceutical Machinery, Jornen Machinery, Lodha International, Yangzhou Nuoya Machinery, Jinzhou Wonder Packing Machinery, Visual Packaging, Zhejiang Hope Machinery

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 131 pages
Market size 2025
$557
Million USD
Forecast CAGR
5%
2025-2032
Forecast 2032
$783.8
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Automatic Medicine Blister Packaging Machine market size is predicted to grow from US$ 557 million in 2025 to US$ 782 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.

An automatic medicine blister packaging machine is a device used in the pharmaceutical industry to package individual doses of medications or pills into blister packs. Blister packs are pre-formed plastic or aluminum cavities that hold each dose of medication securely and provide protection against moisture, tampering, and contamination. In 2025, global Automatic Medicine Blister Packaging Machine production reached approximately 8,129 units, with an average global market price of around 70 K US$/Unit. The production capacity of Automatic Medicine Blister Packaging Machine reaches 10,800 units, and the industry's gross profit margin is approximately between 25% and 45%.

Automatic pharmaceutical blister packaging machines have evolved from standalone forming and sealing units into integrated automated packaging systems that combine thermoforming or cold forming, automatic feeding, vision inspection, heat sealing, coding, die-cutting, rejection, serialization and traceability, cartoning line integration, and data recording capabilities. Current market demand is primarily concentrated in packaging applications for tablets, capsules, softgels, OTC medications, prescription drugs, clinical samples, and select medical consumables. Industry growth is driven by factors such as the global expansion of solid dosage manufacturing capacity, increased consumption of generic and OTC drugs, heightened requirements for pharmaceutical safety and moisture barrier protection, pharmaceutical companies' pursuit of GMP compliance and production efficiency upgrades, rising demand for high-barrier aluminum-aluminum packaging, and the widespread adoption of cartoning line integration and serialization traceability systems. Large pharmaceutical enterprises tend to prioritize the acquisition of high-speed, integrated blister-to-carton lines to boost production capacity, minimize manual labor, and reduce packaging errors; conversely, small-to-medium-sized pharmaceutical firms and CDMOs place greater emphasis on rapid changeover capabilities, material compatibility, and the capacity for multi-product, small-batch production. Moving forward, automatic pharmaceutical blister packaging machines will continue to evolve toward higher speeds, greater flexibility, intelligent inspection capabilities, data traceability, energy efficiency and waste reduction, and compatibility with sustainable packaging materials.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automatic Medicine Blister Packaging Machine market?

What factors are driving Automatic Medicine Blister Packaging Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automatic Medicine Blister Packaging Machine market opportunities vary by end market size?

How does Automatic Medicine Blister Packaging Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Automatic Medicine Blister Packaging Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Roller Automatic Medicine Blister Packaging Machine
  • Tablet Automatic Medicine Blister Packaging Machine

Segment by Production Speed

  • Low Speed
  • Medium Speed
  • High Speed

Segment by Process

  • Continuous Blister Packaging Machine
  • Intermittent Blister Packaging Machine

Segment by Application

  • Tablets
  • Capsules
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Automatic Medicine Blister Packaging Machine market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Tablets, Capsules, Others evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Automatic Medicine Blister Packaging Machine Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$557
2025
Forecast
$783.8
2032
CAGR
5%
2025–2032
Regions
5
global
Key companies
UhlmannIMA GroupMarchesiniRomacoKörber PharmaPharmaworksHoong-ACAM
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Roller Automatic Medicine Blister Packaging MachineTablet Automatic Medicine Blister Packaging Machine
By Application
TabletsCapsulesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Roller Automatic Medicine Blister Packaging Machine
  • 3.1.3 Tablet Automatic Medicine Blister Packaging Machine
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Tablets
  • 4.1.3 Capsules
  • 4.1.4 Others
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Uhlmann
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 IMA Group
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Marchesini
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Romaco
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Körber Pharma
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Pharmaworks
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Hoong-A
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 CAM
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Mutual Corporation
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 ACG Pam Pac
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Algus Packaging
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Hualian Pharmaceutical Machinery
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Jornen Machinery
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Lodha International
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Yangzhou Nuoya Machinery
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Jinzhou Wonder Packing Machinery
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Visual Packaging
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Zhejiang Hope Machinery
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Automatic Medicine Blister Packaging Machine market?
The global Automatic Medicine Blister Packaging Machine market is estimated at US$ 557 million in 2025 (base year) and is projected to reach US$ 782 million by 2032.
What is the forecast CAGR for the Automatic Medicine Blister Packaging Machine market?
The market is expected to grow at a CAGR of 5.0% from 2026 to 2032, expanding from US$ 557 million in 2025 to US$ 782 million in 2032, roughly 1.4 times its base-year value.
What is Automatic Medicine Blister Packaging Machine?
An automatic medicine blister packaging machine is a device used in the pharmaceutical industry to package individual doses of medications or pills into blister packs. Blister packs are pre-formed plastic or aluminum cavities that hold each dose of medication securely and provide protection against moisture, tampering, and contamination. In 2025, global Automatic Medicine Blister Packaging Machine production reached approximately 8,129 units, with an average global market price of around 70 K US$/Unit.
How is the Automatic Medicine Blister Packaging Machine market segmented by type?
By type, the market is segmented into Roller Automatic Medicine Blister Packaging Machine and Tablet Automatic Medicine Blister Packaging Machine.
What are the key applications of Automatic Medicine Blister Packaging Machine?
Key applications covered include Tablets, Capsules and Others.
Which companies are profiled in the Automatic Medicine Blister Packaging Machine market report?
Key players profiled include Uhlmann, IMA Group, Marchesini, Romaco, Körber Pharma, Pharmaworks, Hoong-A and CAM, among 18 companies covered in total.
What geographies does the Automatic Medicine Blister Packaging Machine market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Automatic Medicine Blister Packaging Machine?
What factors are driving Automatic Medicine Blister Packaging Machine market growth, globally and by region?
Who should buy the Automatic Medicine Blister Packaging Machine market report?
The report is intended for manufacturers and solution providers, distributors and end users in Tablets, Capsules and Others, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Automatic Medicine Blister Packaging Machine market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600